The Bay Area Reporter - November 19, 1999
Terry Beswick
Earlier this month, Bristol-Myers Squibb, manufacturer of AIDS drugs ddI and d4T, gave San Francisco's Tenderloin AIDS Resource Center (TARC) $35,000. The money is being used to triple the size of the group's HIV testing and treatment education programs.
"It has allowed us to offer HIV antibody testing and results on demand to a population that has trouble keeping appointments," said Paul Causey, TARC's executive director.
HIV testing and counseling will now be available on a drop-in basis for homeless people at high risk for HIV infection 30 hours each week at TARC's storefront operation at 187 Golden Gate Avenue. And for those newly infected with HIV, TARC will provide treatment advocacy counseling at the Tom Waddell Health Clinic on Ivy Street.
Founded in 1990, TARC has become a focal point for AIDS and HIV prevention information, referral, and service coordination in the Tenderloin and South of Market neighborhoods. Now working with an $800,000 annual budget, its workers and volunteers also provide testing, prevention education, and safe sex supplies in local parks, residential hotels, on street corners, and at the TARC late night drop-in center.
TARC began offering HIV antibody testing in 1998 with $3,500 from the San Francisco Department of Public Health.
Pharmaceuticals have supported HIV testing and early intervention programs for many years, and Causey had no qualms about taking money from a maker of AIDS drugs for funding of a treatment education program.
"Bristol Myers was very blunt about why they were doing this û to get people into treatment quicker," he said, adding that no particular drug will be promoted to TARC's clients. "That's everyone's goal, to make sure that people have the information to make a decision."
The TARC program is designed to link HIV test counseling with treatment advocacy, Causey emphasized, to ensure that homeless people testing positive have immediate access to supportive and potentially life-saving information and services.
For more information about TARC's services, call (415) 431-7476.
991119
BR991105
Copyright © 1999 - The Bay Area Reporter. Reproduction of this article (other than one copy for personal reference) must be cleared through the The Bay Area Reporter.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .